BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3023409)

  • 1. Somatic events unmask recessive cancer genes to initiate malignancy.
    Gallie BL; Worton RG
    J Cell Biochem; 1986; 32(3):215-22. PubMed ID: 3023409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.
    Friend SH; Bernards R; Rogelj S; Weinberg RA; Rapaport JM; Albert DM; Dryja TP
    Nature; 1986 Oct 16-22; 323(6089):643-6. PubMed ID: 2877398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recessive oncogene and loss of heterozygosity].
    Sasaki M; Ejima Y; Ishizaki K; Toguchida J; Kato M
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):624-31. PubMed ID: 2650634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioncogenes: models for tumors in children].
    Junien C; Henry I; Jeanpierre C; Lavedan C; Antignac C; Puech A; Beroud C
    Bull Cancer; 1991 Jan; 78(1):57-68. PubMed ID: 2021687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and molecular aspects of human multigenerational carcinogenesis.
    Evans HJ
    IARC Sci Publ; 1989; (96):315-33. PubMed ID: 2553599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prince Takamatsu memorial lecture. Rare cancers: clues to genetic mechanisms.
    Knudson AG
    Princess Takamatsu Symp; 1987; 18():221-31. PubMed ID: 2852189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of oncogenesis.
    Seemayer TA; Cavenee WK
    Lab Invest; 1989 May; 60(5):585-99. PubMed ID: 2654471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current knowledge of heritable tumors.
    Cavenee WK
    Birth Defects Orig Artic Ser; 1989; 25(2):29-43. PubMed ID: 2655740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of human cancer.
    Knudson AG
    Annu Rev Genet; 1986; 20():231-51. PubMed ID: 2880556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recessive cancer genes and chromosomal mechanisms in tumorigenesis.
    Nordenskjöld M; Lundberg C
    Ann Clin Res; 1986; 18(5-6):307-13. PubMed ID: 3032067
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma.
    Brodeur GM
    Cancer Surv; 1995; 25():67-99. PubMed ID: 8718513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal mechanisms in the initiation of human familial mixed cancers.
    Cavenee WK
    Princess Takamatsu Symp; 1986; 17():171-9. PubMed ID: 3332009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.
    Toguchida J; Ishizaki K; Sasaki MS; Ikenaga M; Sugimoto M; Kotoura Y; Yamamuro T
    Cancer Res; 1988 Jul; 48(14):3939-43. PubMed ID: 2898286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary cancer and its clinical implications: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
    Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic predisposition to cancer.
    Knudson AG
    Cancer Detect Prev; 1984; 7(1):1-8. PubMed ID: 6367981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.
    Brodeur GM
    Prog Hematol; 1986; 14():229-56. PubMed ID: 3003796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.